Vascular endothelial growth factor receptor-3 (VEGFR-3): A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas

Modern Pathology

Volumn 13, Issue 2, 2000, Pages 180-185

  Folpe, Andrew L ^a,c   Veikkola, Tanja ^b   Valtola, Reija ^b   Weiss, Sharon W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Angiosarcoma; Kaposi's sarcoma; Lymphatics; Vascular endothelial growth factor receptors

Indexed keywords

CD31 ANTIGEN; RECEPTOR ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3; VON WILLEBRAND FACTOR;

ANGIOSARCOMA; ANTIGEN EXPRESSION; ARTICLE; DERMATITIS; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; LYMPHANGIOMA; LYMPHATIC SYSTEM; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYOGENIC GRANULOMA; TISSUE DIFFERENTIATION; VASCULAR TUMOR;

EID: 0033955742     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880033     Document Type: Article

References (31)

1. Scully PA, Steinman HK, Kennedy C, Trueblood K, Frisman DM, Voland JR. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. Am J Pathol 1988;130(2):244-51.
2. Dictor M, Andersson C. Lymphaticovenous differentiation in Kaposi's sarcoma: cellular phenotypes by stage. Am J Pathol 1988;130(2):4H-7 [published erratum appears in 133(2):226].
3. Zhang YM, Bachmann S, Hemmer C, van Lunzen J, von Stemm A, Kern P, et al. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombo-modulin, and tissue factor. Am J Pathol 1994;144(1):51-9.
4. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998; 58(8):1599-604.
5. Hoerl HD, Goldblum JR. Immunoreactivity patterns of CD31 and CD68 in 28 cases of Kaposi's sarcoma: evidence supporting endothelial differentiation in the spindle cell component. Appl Immunohistochem 1997;5(3):173-8.
6. Kostianovsky M, Lamy Y, Greco MA. Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. Ultrastruct Pathol 1992; 16(6):629-40.
7. Rutgers JL, Wieczorek R, Bonetti F, Kaplan KL, Posnett DN, Friedman-Kien AE, et al. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma: evidence for a vascular endothelial cell origin. Am J Pathol 1986;122(3):493-9.
8. Dorfman RF, Wood GS, Beckstead JH. Histogenesis of Kaposi's sarcoma. Kaposi's sarcoma: pathophysiology and clinical management. Ziegler JL, Dorfman RF, eds. New York, Marcel Dekker, p 1988.
9. Facchetti F, Lucini L, Gavazzoni R, Callea F. Immunomorphological analysis of the role of blood vessel endothelium in the morphogenesis of cutaneous Kaposi's sarcoma: a study of 57 cases. Histopathology 1988;12(6):581-93.
10. Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998;153(2):395-403.
11. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7(1):82-90.
12. Suster S, Nascimento AG, Miettinen M, Sickel JZ, Moran CA. Solitary fibrous tumors of soft tissue: a clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol 1995;19(11):1257-66.
13. Suster S, Fisher C. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997;21(2):195-200.
14. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions [see comments]. Am J Surg Pathol 1993; 17(10):1039-45.
15. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18(1):4-25.
16. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276(5317): 1423-5 [published erratum appears in 277(53255:463].
17. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol (Orlando) 1997; 188(15:96-109.
18. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92(8):3566-70.
19. van de Rijn M, Rouse R. CD34: a review. Appl Immunohistochem 1994;2(2):71-80.
20. Sankey EA, More L, Dhillon AP. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma [see comments]. J Pathol 1990;161(3):267-71.
21. Watt SM, Gschmeissner SE, Bates PA. PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk Lymphoma 1995;17(3-4): 229-44.
22. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, et al. Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis. Clin Immunol Immunopathol 1995;76(2):180-6.
23. De Young BR, Frierson HF, Jr., Ly MN, Smith D, Swanson PE. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 1998;110(3):374-7.
24. Smith ME, Brown JI, Fisher C. Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin. Histopathology 1998;33(5):425-31.
25. McNutt NS, Fletcher V, Conant MA. Early lesions of Kaposi's sarcoma in homosexual men: an ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 1983; 111(1):62-77.
26. Beckstead JH, Wood GS, Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol 1985;119(2):294-300.
27. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43(9):752-7.
28. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells: differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 1998;46(2):165-76.
29. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17(4):321-8.
30. Dabska M. Malignant endovascular papillary angioendothelioma of the skin in childhood: clinicopathologic study of 6 cases. Cancer 1969;24(3):503-10.
31. Mentzel T, Mazzoleni G, Dei Tos AP, Fletcher CD. Kaposiform hemangioendothelioma in adults: clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol 1997;108(4):450-5.